Ozgen Alpaydin Aylin, Ozuygur Saliha Selin, Sahan Ceyda, Tertemiz Kemal Can, Russell Richard
Department of Pulmonary Diseases, Dkuz Eylül University, Faculty of Medicine, İzmir, Turkey.
Department of Public Health, Hacettepe University, Faculty of Medicine, Ankara, Turkey.
Turk Thorac J. 2021 Sep;22(5):369-375. doi: 10.5152/TurkThoracJ.2021.0189.
Readmission after hospitalization for a chronic disease is a major concern of interest for health care quality. Our aim was to investigate the predictors and rates of early readmission after an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in a tertiary care hospital.
Over a 3-year period, patients hospitalized in our pulmonary disease clinic with a diagnosis of chronic obstructive pulmonary disease (COPD) and who had an index hospitalization for AECOPD were included. Readmission was defined as rehospitalization within 30 days of AECOPD discharge. Demographics, comorbidities, exacerbations, prior intensive care unit (ICU) stay, and long-term oxygen therapy (LTOT), blood eosinophil count, and antibiotic and/or steroid treatment at the index AECOPD admission were recorded.
Fifty-two (17.3%) readmissions occurred in 300 patients. Readmissions were due to AECOPD in 46.2%, pneumonia in 19.2%, and cardiovascular disease in 15.4% patients. Twenty-one (40%) of the readmitted patients were frequent exacerbators. After adjusting for individual and clinical predictors, the odds ratio for readmission was 2.11 (95% CI, 1.07-4.15, P = .03) for those with congestive heart failure, 3.30 (95% CI, 1.05-9.75, P = .04) for those with arrhythmia, and 1.99 (95% CI, 1.04-3.81, P = .04) for LTOT users prior to AECOPD.
A significant majority of patients readmitted after an AECOPD mainly suffered from recurrent AECOPD. Associated congestive heart failure, arrhythmia, and prior LTOT were risk factors identified for early AECOPD readmissions in our study. Better recognition of readmission risk factors might help to reduce readmission rates of AECOPD.
慢性病住院后的再入院是医疗质量关注的一个主要问题。我们的目的是调查三级医院中慢性阻塞性肺疾病急性加重(AECOPD)后早期再入院的预测因素和发生率。
在3年期间,纳入我院肺病门诊诊断为慢性阻塞性肺疾病(COPD)且因AECOPD进行首次住院治疗的患者。再入院定义为AECOPD出院后30天内再次住院。记录患者的人口统计学资料、合并症、病情加重情况、既往重症监护病房(ICU)住院史、长期氧疗(LTOT)、血液嗜酸性粒细胞计数以及首次AECOPD入院时的抗生素和/或类固醇治疗情况。
300例患者中有52例(17.3%)再次入院。再入院原因中,46.2%是由于AECOPD,19.2%是肺炎,15.4%是心血管疾病。21例(40%)再入院患者是频繁病情加重者。在对个体和临床预测因素进行校正后,充血性心力衰竭患者再入院的比值比为2.11(95%可信区间,1.07 - 4.15,P = 0.03),心律失常患者为3.30(95%可信区间,1.05 - 9.75,P = 0.04),AECOPD之前使用LTOT的患者为1.99(95%可信区间,1.04 - 3.81,P = 0.04)。
AECOPD后再入院的患者中,绝大多数主要患有复发性AECOPD。在我们的研究中,相关的充血性心力衰竭、心律失常以及既往LTOT是AECOPD早期再入院的危险因素。更好地识别再入院危险因素可能有助于降低AECOPD的再入院率。